Healthcare
Monday, December 19, 2016
CORRECTED-UPDATE 1-Ionis Pharma's rare metabolic disorder drug succeeds key study
Dec 19 (Reuters) - Ionis Pharmaceuticals Inc said
on Monday its rare metabolic disorder drug for severe
hypertriglyceridemia, characterized by elevated levels of a type
of fat in the blood, met the main goal in a late-stage study.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment